Revolutionizing Drug Discovery with Atomwise's AtomNet® Technology

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Products-Atomwise

Revolutionizing Drug Discovery with Atomwise's AtomNet® Technology

Innovative Approach to Drug Discovery

Atomwise's groundbreaking AtomNet® technology is revolutionizing the field of small molecule drug discovery by tackling the most challenging and previously considered impossible targets. By streamlining the drug discovery process, Atomwise empowers drug developers with more opportunities for success.

Differentiated Computational Methods

Atomwise sets itself apart from other computational drug discovery methods with its unique capabilities. It can effectively target poorly categorized molecules without the need for crystal structures or local ligand training data. The platform's ability to explore vast chemical space computationally efficiently allows for screening of trillions of compounds in silico, increasing the chances of identifying successful drug candidates. Moreover, Atomwise's model accuracy is commendable, overcoming the issue of false positives.

Scalable Discovery Engine

Atomwise boasts a globally applicable model that can be rapidly scaled, offering an industrialized discovery process. This scalability is vital in expediting drug development and ensuring a wide range of targets can be addressed. The network effects driving model predictability continuously evolve, enhancing the global model's accuracy with each data set generated.

AI/ML Advancements in Drug Discovery

Atomwise's pioneering use of artificial intelligence and machine learning in molecular recognition has significantly advanced the field of drug discovery. By leveraging technology similar to that used for image recognition, Atomwise's AtomNet® technology has successfully identified small molecule hits for more traditionally undruggable targets than any other AI platform. This innovative approach accelerates the discovery of new medicines and offers hope for addressing previously unmet medical needs.

Cutting-Edge Engineering Architecture

The AtomNet® platform is built upon cutting-edge tools for artificial intelligence and machine learning, enabling scalability and speed crucial for developing a comprehensive pipeline of drugs. Atomwise's technological prowess extends to partnerships with technical experts, ensuring that the platform remains at the forefront of drug discovery innovation.

Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive seamless operations, and scale effortlessly for long-term success.

Book A Meeting To Setup A VDC

Revolutionizing Drug Discovery with Atomwise's Award-Winning AtomNet® Technology

Atomwise's Approach to Drug Discovery

Atomwise is revolutionizing the field of small molecule drug discovery with their cutting-edge AtomNet® technology. This innovative approach enables researchers to tackle the most challenging and previously considered impossible drug targets, significantly streamlining the drug discovery process. By leveraging advanced computational methods, Atomwise provides drug developers with more opportunities for success in developing new treatments.

Read article

Advancing Scientific Discovery Through Research Partnerships with Atomwise

Partnering with Top Researchers Globally

Atomwise, a pioneering company in AI-driven drug discovery, has collaborated with leading academic, government, and non-profit research institutes worldwide to tackle complex chemistry challenges and validate the effectiveness of their cutting-edge technology. Through the AIMS program, Atomwise has established over 250 partnerships with top universities and research institutions, resulting in the development of joint intellectual property in innovative compounds. These collaborative efforts have addressed more than 600 unique targets across various disease areas, demonstrating the diverse applications and impact of Atomwise's technology in advancing scientific research.

Read article

Revolutionizing Drug Discovery with Atomwise AI Technology

Atomwise: Pioneering AI Drug Discovery

Atomwise, a leading company in the field of AI drug discovery, has been making waves in the pharmaceutical industry with its innovative technology. By harnessing the power of artificial intelligence, Atomwise is revolutionizing the way new drugs are discovered and developed. The company's cutting-edge platform utilizes advanced algorithms to analyze vast amounts of molecular data and predict the potential effectiveness of new drug compounds. This predictive modeling not only accelerates the drug discovery process but also increases the likelihood of identifying promising drug candidates that may have been overlooked using traditional methods.

Read article

Empowering Innovation: Atomwise Research Partnerships

Global Collaboration for Breakthrough Solutions

Atomwise, a leading AI-driven drug discovery company, offers an innovative approach to research partnerships that has yielded remarkable results. Through collaborations with academic, government, and non-profit research institutes, Atomwise has tackled complex chemistry challenges and validated its cutting-edge technology. With over 250 partnerships established under the AIMS program, Atomwise has engaged with top universities and research institutes worldwide to drive scientific advancements. These collaborations have led to the development of joint intellectual property in novel compounds, paving the way for groundbreaking discoveries across various disease areas.

Read article

Welcome to Knowledge Base!

KB at your finger tips

Products-Atomwise